RxDoctor Payments Data

Christina D'angelis

Medical · Staten Island, NYNPI 1417084682

Payments from drug & device makers

$7,638in general payments, 2019–2025

Across 338 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$980
  • GSK$696
  • Lilly USA, LLC$574
  • Takeda Pharmaceuticals U.S.A., Inc.$394
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$7,638100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,638 in reported general payments places this provider in the 90th percentile of 2,395 medical providers in New York.

See all medical providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol17$16,896
Janumet XrSitagliptin Phos/Metformin Hcl15$11,256
VascepaIcosapent Ethyl14$5,314
SynthroidLevothyroxine Sodium55$4,019
Rosuvastatin Calcium182$2,563
Metoprolol Succinate127$1,701
Atorvastatin Calcium155$1,623
Albuterol Sulfate HfaAlbuterol Sulfate54$1,606
Escitalopram Oxalate45$1,366
Levothyroxine Sodium127$1,162
Losartan Potassium97$1,020
Telmisartan40$882
Omeprazole53$798
Fluticasone Propionate58$775
Cephalexin27$742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$2,345$16,89617 claims
AbbVieSynthroid$1,306$4,01955 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,395 medical providers in New York.

Other medical in Staten Island

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →